Study of Carboplatin/Paclitaxel With or Without Investigational Drug (CS-7017) in Subjects With Metastatic Non-small Cell Lung Cancer
Public ClinicalTrials.gov record NCT00806286. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 2 Randomized Study of Carboplatin/Paclitaxel With or Without CS-7017 in Chemotherapy-Naïve Subjects With Metastatic Non-Small Cell Lung Cancer
Study identification
- NCT ID
- NCT00806286
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Daiichi Sankyo
- Industry
- Enrollment
- 111 participants
Conditions and interventions
Conditions
Interventions
- CS7017 tablets Drug
- Carboplatin Drug
- Paclitaxel Drug
- Placebo Tablets Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2008
- Primary completion
- Dec 31, 2011
- Completion
- Jul 31, 2012
- Last update posted
- May 12, 2020
2008 – 2012
United States locations
- U.S. sites
- 10
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University Colorado Cancer Center | Aurora | Colorado | 80045 | — |
| Georgetown Univ. Medical Center | Washington D.C. | District of Columbia | 20007 | — |
| Southern Illinois Hematology/Oncology | Centralia | Illinois | 45042 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Michiana Hematology-Oncology | South Bend | Indiana | 46601 | — |
| Harbor View Cancer Center | Baltimore | Maryland | 21225 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Signal Point Clinical Research Center | Middletown | Ohio | 62801 | — |
| Penn State Milton Hershey Cancer Center | Hershey | Pennsylvania | 17033 | — |
| Eastern Virginia Medical School | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00806286, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 12, 2020 · Synced Apr 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00806286 live on ClinicalTrials.gov.